View Author
scopus: 28367959900

Sombogaard, F.

(Ferdi Sombogaard)


impdh impdh activity activity patient concentration transplantation transplant study sample level mycophenolate mofetil dehydrogenase monophosphate mycophenolate mycophenolic acid mycophenolic inosine mofetil method assay transplant recipients recipient impdh type i expression plasma blood pharmacokinetic therapy value monitoring variability enzyme mpa concentrations correlation mpa concentration pharmacodynamic rejection chapter transplant patients group polymorphism protein albumin model effect difference day 6 van gelder t kidney inhibition table impdh activity assay outcome result impdh type ii impdh mrna levels mpa cl glander hsct patients mpa auc figure visit monit variant parameter determination mmf therapy kidney transplantation hambach p activiteit impdh type 1 ic 50 curve relationship netherland gelder inter-patient variability analysis pharmacol patien




7 Most Recent Publications

Nonlinear relationship between mycophenolate mofetil dose and mycophenolic acid exposure: Implications for therapeutic drug monitoring (Article)
Winter, B.C.M. de Mathot, R.A.A. Sombogaard, F. Vulto, A.G. Gelder, T. van
2011-03-01
Differences in clearance of mycophenolic acid among renal transplant recipients, hematopoietic stem cell transplant recipients, and patients with autoimmune disease (Article)
Winter, B.C.M. de Mathot, R.A.A. Sombogaard, F. Neumann, I. Hest, R.M. van Doorduijn, J.K. Gelder, T. van
2010-10-01
Pharmacodynamic Monitoring of Inosine Monophosphate Dehydrogenase Activity: A Basis For Optimized and Individualized Mycophenolate Mofetil Therapy (Doctoral Thesis)
Sombogaard, F.
2010-03-12
Pharmacokinetic role of protein binding of mycophenolic acid and its glucuronide metabolite in renal transplant recipients (Article)
Winter, B.C.M. de Gelder, T. van Sombogaard, F. Shaw, L.M. Hest, R.M. van Mathot, R.A.
2009-12-01
Inosine monophosphate dehydrogenase messenger RNA expression is correlated to clinical outcomes in mycophenolate mofetil-treated kidney transplant patients, whereas inosine monophosphate dehydrogenase activity is not (Article)
Sombogaard, F. Peeters, A.M.A. Baan, C.C. Mathot, R.A.A. Quaedackers, M.E. Vulto, A.G. Weimar, W. Gelder, T. van
2009-10-01
Interpatient variability in IMPDH activity in MMF-treated renal transplant patients is correlated with IMPDH type II 3757T>C polymorphism (Article)
Sombogaard, F. Schaik, R.H.N. van Mathot, R.A. Budde, K. Werf, M. van der Vulto, A.G. Weimar, W. Glander, P. Essioux, L. Gelder, T. van
2009-08-01
Improved assay for the nonradioactive determination of inosine 5'-monophosphate dehydrogenase activity in peripheral blood mononuclear cells (Article)
Glander, P. Sombogaard, F. Mathot, R.A. Budde, K. Gelder, T. van Hambach, P. Liefeldt, L. Lorkowski, C. Mai, M. Neumayer, H.H. Vulto, A.G.
2009-06-01